Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glioma

Int J Radiat Oncol Biol Phys. 1979 Sep;5(9):1589-92. doi: 10.1016/0360-3016(79)90778-8.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Bone Marrow / drug effects
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / radiotherapy
  • Clinical Trials as Topic
  • Drug Therapy, Combination
  • Female
  • Glioblastoma / drug therapy*
  • Glioblastoma / radiotherapy
  • Humans
  • Hydroxyurea / administration & dosage*
  • Hydroxyurea / adverse effects
  • Lomustine / administration & dosage*
  • Lomustine / adverse effects
  • Male
  • Middle Aged
  • Nitrosourea Compounds / administration & dosage*
  • Vincristine / administration & dosage*
  • Vincristine / adverse effects

Substances

  • Nitrosourea Compounds
  • Vincristine
  • Lomustine
  • Hydroxyurea